LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.48
+0.43 (8.51%)
At close: Jul 24, 2026, 4:00 PM EDT
5.38
-0.10 (-1.82%)
After-hours: Jul 24, 2026, 7:34 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $171.82 million as of July 24, 2026. Its market cap has decreased by -81.53% in one year.
Market Cap
171.82M
Enterprise Value
-85.89M
1-Year Change
-81.53%
Ranking
Category
Stock Price
$5.48
ChartMarket Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $171.82M, a decrease of -58.46%. That is a compound annual growth rate of -31.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 171.82M | -65.68% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 177.20M |
| Jyong Biotech | 175.19M |
| NervGen Pharma | 173.11M |
| Alpha Cognition | 172.02M |
| Armata Pharmaceuticals | 171.07M |
| Corbus Pharmaceuticals Holdings | 169.90M |
| Innate Pharma | 169.81M |
| Humacyte | 168.47M |